Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study)
GHDx Entry last modified on: Jan 31, 2024
COVID-19
Dataset Records for COVID-19
Displaying 151 - 200 of 1561
Maternal Outcomes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Vaccinated Compared With Unvaccinated Pregnant Patients
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico
GHDx Entry last modified on: Apr 10, 2023
Identification of spectrum of persistent post-COVID-19 symptoms and their duration in Central India: A pilot study
GHDx Entry last modified on: Mar 22, 2024
Incidence and Characterization of Post-COVID-19 Symptoms in Hospitalized COVID-19 Survivors to Recognize Syndemic Connotations in India: Single-Center Prospective Observational Cohort Study
GHDx Entry last modified on: Mar 22, 2024
Evaluation of bacterial coinfections and susceptible antibiotic profiles in hospitalized COVID-19 patients in Koya district, Iraq
GHDx Entry last modified on: Sep 17, 2024
Analysis of Post-COVID-19 Guillain-Barré Syndrome over a Period of One Year in the University Hospital of Split (Croatia)
GHDx Entry last modified on: Oct 23, 2024
Brazil - Tocantins COVID-19 Epidemiological Bulletin 2021
Boletim Epidemiológico Notificação para COVID-19 2021
Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021. Preprint
GHDx Entry last modified on: May 12, 2022
COVID-19 antibody seroprevalence in Duhok, Kurdistan Region, Iraq: A population-based study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Post-COVID-19 Syndrome: Nine Months after SARS-CoV-2 Infection in a Cohort of 354 Patients: Data from the First Wave of COVID-19 in Nord Franche-Comté Hospital, France
GHDx Entry last modified on: Nov 11, 2024
SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 seroprevalence in Chattogram, Bangladesh before a National Lockdown, March-April 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study
GHDx Entry last modified on: Apr 10, 2023
Herd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic
GHDx Entry last modified on: Apr 10, 2023
United States Behavioral Risk Factor Surveillance System 2021
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative
Characteristics and predictors of Long COVID among diagnosed cases of COVID-19
GHDx Entry last modified on: Mar 22, 2024
Post COVID-19 condition after delta infection and omicron reinfection in children and adolescents
GHDx Entry last modified on: Mar 22, 2024
Twelve Months and Counting: Following Clinical Outcomes in Critical COVID-19 Survivors
GHDx Entry last modified on: Mar 22, 2024
Seroprevalence of anti-SARS-CoV-2 antibodies six months into the vaccination campaign in Geneva, Switzerland. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Herd Immunity of the Kyrgyz Population in 2021. Preprint
GHDx Entry last modified on: Apr 8, 2022
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
GHDx Entry last modified on: Apr 10, 2023
A clinical case definition of post-COVID-19 condition by a Delphi consensus
GHDx Entry last modified on: Dec 12, 2023
The Persistent Symptoms and Decreased Quality of Life of COVID-19 Patients (A 3-month Follow-up after Discharge)
GHDx Entry last modified on: Mar 22, 2024
Long-term health consequences of COVID-19 in survivors hospitalised at a tertiary care hospital and their correlation with acute COVID-19 severity and associated risk factors
GHDx Entry last modified on: Mar 22, 2024
United States COVID Tracking Project 2021
The COVID Tracking Project at The Atlantic
Canada - Ontario Daily Epidemiological Summary of COVID-19 2021
Epidemiologic Summary COVID-19 in Ontario
Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, 2021, Phase 5 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 5
IgG Antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals might need just one vaccine dose
GHDx Entry last modified on: Mar 14, 2022
A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants
GHDx Entry last modified on: Mar 22, 2024
Japan Provisional Cases of Notifiable Diseases by Prefecture 2021
IDWR Surveillance Data Table 2021: Notifiable Diseases
Epi surveillance:
Subnationally representative
SARS-CoV-2 seroprevalence in Kaduna State, Nigeria during October/November 2021, following three waves of infection and immediately prior to detection of the Omicron variant
GHDx Entry last modified on: Jan 31, 2024
Guatemala Vital Statistics 2021
Vital registration:
Subnationally representative
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: B.1.1.7 2021
GHDx Entry last modified on: Jun 14, 2023
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey. Preprint
GHDx Entry last modified on: Mar 14, 2022
Zimbabwe COVID-19 Daily Update 2021
GHDx Entry last modified on: Dec 22, 2022
Peru Demographic and Family Health Survey 2021
Encuesta Demográfica y de Salud Familiar (ENDES) 2021
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
Trajectory of Post-COVID Self-Reported Fatigue and Dyspnoea in Individuals Who Had Been Hospitalized by COVID-19: The LONG-COVID-EXP Multicenter Study
GHDx Entry last modified on: Mar 22, 2024
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: B.1.351 2021
GHDx Entry last modified on: Jun 14, 2023
Socioeconomic position and SARS-CoV-2 infections: seroepidemiological findings from a German nationwide dynamic cohort. Preprint
GHDx Entry last modified on: Mar 14, 2022
Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: B.1.525 2021
GHDx Entry last modified on: Jun 14, 2023
Results of Serosurveillance and Forecasting the Third Wave of COVID-19 in an Industrial District in India
GHDx Entry last modified on: Jan 31, 2024
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: P.1 2021
GHDx Entry last modified on: Jun 14, 2023
Seroprevalence of Antibodies Specific to Receptor Binding Domain of SARS-CoV-2 and Vaccination Coverage Among Adults in Los Angeles County, April 2021: The LA Pandemic Surveillance Cohort Study
GHDx Entry last modified on: Jan 31, 2024
Yemen Supreme National Emergency Committee for COVID-19 Daily Report 2021
GHDx Entry last modified on: Aug 24, 2023
Subscribe